Morphine induces splenocyte apoptosis and enhanced mRNA expression of cathepsin-B
- PMID: 9429908
- DOI: 10.1023/a:1027334122387
Morphine induces splenocyte apoptosis and enhanced mRNA expression of cathepsin-B
Abstract
Morphine has been demonstrated to modulate immune function. We studied whether morphine modulates apoptosis of splenocytes. Splenocytes were isolated from control and morphine treated rats. Splenocytes isolated from morphine treated rats showed increased percentage (P < 0.001) of apoptosis when compared to splenocytes isolated from untreated rats (control, 4.7 +/- 1.0% apoptotic splenocytes/field vs. morphine, 47.8 +/- 3.4% apoptotic splenocytes/field). These results were further confirmed by gel electrophoresis as well as by end-labeling DNA of splenocytes isolated from control and morphine treated rats. Splenocytes from morphine treated rats showed a classical ladder pattern with integer multiples of 180 base pairs. Splenocytes from morphine treated rats also showed increased mRNA expression of cathepsin-B, a gene associated with active cell death. These results suggest that morphine may also be modulating immune function by enhancing apoptosis of splenocytes.
Similar articles
-
Age and sex modulate renal expression of SGP-2 and transglutaminase and apoptosis of splenocytes, thymocytes, and macrophages.J Investig Med. 1997 Dec;45(9):567-75. J Investig Med. 1997. PMID: 9444884
-
Morphine-induced macrophage apoptosis: the role of transforming growth factor-beta.Immunology. 2000 May;100(1):57-62. doi: 10.1046/j.1365-2567.2000.00007.x. Immunology. 2000. PMID: 10809959 Free PMC article.
-
Morphine induces splenocyte trafficking into the CNS.J Neuroimmune Pharmacol. 2012 Jun;7(2):436-43. doi: 10.1007/s11481-011-9307-2. Epub 2011 Aug 20. J Neuroimmune Pharmacol. 2012. PMID: 21858458 Free PMC article.
-
Morphine modulates proliferation of kidney fibroblasts.Kidney Int. 1998 Feb;53(2):350-7. doi: 10.1046/j.1523-1755.1998.00758.x. Kidney Int. 1998. PMID: 9461094
-
Modulation of immune function by morphine: implications for susceptibility to infection.J Neuroimmune Pharmacol. 2006 Mar;1(1):77-89. doi: 10.1007/s11481-005-9009-8. J Neuroimmune Pharmacol. 2006. PMID: 18040793 Review. No abstract available.
Cited by
-
Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.Eur J Neurosci. 2004 Jun;19(12):3171-82. doi: 10.1111/j.0953-816X.2004.03461.x. Eur J Neurosci. 2004. PMID: 15217373 Free PMC article.
-
Opioid administration following spinal cord injury: implications for pain and locomotor recovery.Exp Neurol. 2013 Sep;247:328-41. doi: 10.1016/j.expneurol.2013.03.008. Epub 2013 Mar 15. Exp Neurol. 2013. PMID: 23501709 Free PMC article. Review.
-
Effect of μ-opioid agonist DAMGO on surface CXCR4 and HIV-1 replication in TF-1 human bone marrow progenitor cells.BMC Res Notes. 2014 Oct 23;7:752. doi: 10.1186/1756-0500-7-752. BMC Res Notes. 2014. PMID: 25338959 Free PMC article.
-
Chronic opioid therapy in long-term cancer survivors.Clin Transl Oncol. 2017 Feb;19(2):236-250. doi: 10.1007/s12094-016-1529-6. Epub 2016 Jul 21. Clin Transl Oncol. 2017. PMID: 27443415 Review.
-
Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro.Neuroscience. 2001;102(3):555-63. doi: 10.1016/s0306-4522(00)00461-9. Neuroscience. 2001. PMID: 11226693 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources